New Cystic Fibrosis call launched
The NIHR has launched a new call for research proposals involving people with Cystic Fibrosis (CF).
Cystic Fibrosis is an inherited disorder affecting the lungs, pancreas, liver and intestine. It can have a significant impact on life expectancy and quality of life. Advances in screening, diagnosis and management now means life expectancy has increased significantly over recent years. It also means that individuals are living with a chronic disease and multi-morbidities.
The call aims to support robustly designed studies with the potential to improve health outcomes for patients, the public and social care services. We are particularly interested in studies focused around the burden of care and treatment and how they could be simplified, the diagnosis and management of non-tuberculous mycobacteria, the potential benefits of exercise and possible alternative options to physiotherapy.
Zoë Elliott, a mum to twins who live with Cystic Fibrosis said:
“I’m keenly aware of how important research is to the future of my twins. I was incredibly fortunate to be a parent member of the James Lind Alliance (JLA) Cystic Fibrosis Priority Setting Partnership (PSP) steering committee, I knew that the community had lots of ideas around research and the level of engagement from the patient/carer community demonstrated that. I’m delighted to see the NIHR funding call for CF research proposals and look forward to seeing how the research community reflects the priorities of the cystic fibrosis community.”
The call is being run in a number of our research funding programmes with different open and close dates:
|Programme (including link to funding opportunity when open)||Call open date (stage 1 applications)||Call close date (stage 1 applications)|
|Efficacy and Mechanism Evaluation (EME)||1 October 2020||1 December 2020|
|Health Technology Assessment (HTA)||1 October 2020||6 January 2021|
|Health Services and Delivery Research (HS&DR)||1 October 2020||4 February 2021|
|Programme Grants for Applied Research (PGfAR)||1 October 2020||25 November 2020|
|Programme Development Grants (PDG)||18 November 2020||13 January 2021|
|Research for Patient Benefit (RfPB)||18 November 2020||10 March 2021|